arrow
返回
J

Junji Furuse

kanagawa cancer center

75H指数
730论文数
2.9W被引数
收录论文 168
发表时间
Impact of ERCC1 on the outcomes of chemotherapy in advanced biliary tract cancerERCC1对晚期胆道癌化疗效果的影响
err2025-09-30
err0
errOAAI
errYasunari Sakamoto; Chigusa Morizane; Takuji Okusaka; Junki Mizusawa; Nobuyoshi Hiraoka; Tomoki Shirota; Makoto Ueno; Satoshi Kobayashi; Masafumi Ikeda; Hiroshi Imaoka; Masato Ozaka; Naohiro Okano; Hironori Yamaguchi; Nobumasa Mizuno; Tomohiro Nishina; Akio Katanuma; Yasushi Kojima; Kunihito Gotoh; Keiya Okamura; Yasuyuki Kawamoto; Kazuya Sugimori; Takeshi Terashima; Rie Sugimoto; Hirofumi Shirakawa; Junji Furuse
err分享
err收藏
Outcomes of FOLFIRINOX versus Gemcitabine plus nab-Paclitaxel in Patients with Early Recurrent Pancreatic Cancer after Adjuvant S-1 Treatment: A propensity Score-matched AnalysisFOLFIRINOX与吉西他滨联合nab-紫杉醇在S-1辅助治疗后早期复发性胰腺癌患者中的疗效比较:一项倾向性评分匹配分析
err2025-08-30
err0
PREAI
errNaohiro Okano; Kentaro Sakamaki; Takafumi Mie; Kazuo Watanabe; Satoshi Kobayashi; Akiko Todaka; Yuko Suzuki; Hidetoshi Kitamura; Kazunari Tanaka; Kei Nakagawa; Keiko Kamei; Kumiko Umemoto; Nobuaki Azemoto; Yasuyuki Kawamoto; Hiroaki Yanagimoto; Kunihiro Tsuji; Hiroshi Imaoka; Takeshi Terashima; Chigusa Morizane; Masafumi Ikeda; Masato Ozaka; Makoto Ueno; Junji Furuse
err分享
err收藏
Peritoneum carcinomatosis as a favourable prognostic factor for treatment with nanoliposomal irinotecan and fluorouracil plus leucovorin in advanced pancreatic cancer腹膜癌病作为纳米脂质体伊立替康联合氟尿嘧啶和亚叶酸钙治疗晚期胰腺癌的有利预后因素
err2025-06-26
err0
errOAAI
errSatoshi Kobayashi; Taito Fukushima; Shun Tezuka; Kazumasa Shiraishi; Masato Enomoto; Shotaro Tsunoda; Tomomi Hamaguchi; Ritsuko Ohishi; Yuichiro Tozuka; Masaaki Murakawa; Naoto Yamamoto; Makoto Ueno; Junji Furuse; Shin Maeda
err分享
err收藏
Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCCHIMALAYA研究五-year总体生存率更新:曲美木单抗联合度伐利尤单抗治疗不可切除性HCC
err2025-04-11
err0
errOAAI
errLorenza Rimassa; Stephen L. Chan; Bruno Sangro; George Lau; Masatoshi Kudo; Maria Reig; Valeriy Breder; Min-Hee Ryu; Yuriy Ostapenko; Wattana Sukeepaisarnjaroen; Maria Varela; David Tougeron; Oxana V. Crysler; Mohamed Bouattour; Tu Van Dao; Vincent C. Tam; Adilson Faccio; Junji Furuse; Long-Bin Jeng; Yoon Koo Kang; Robin K. Kelley; Michael J. Paskow; Di Ran; Ioannis Xynos; John F. Kurland; Alejandra Negro; Ghassan K. Abou-Alfa
err分享
err收藏
NALIRIFOX in Japanese treatment-naïve patients with metastatic pancreatic adenocarcinoma: an open-label, phase II trial design
err2025-02-22
err0
errOAAI
errIkeda, Masafumi; Okusaka, Takuji; Ueno, Makoto; Ozaka, Masato; Satoi, Sohei; Skanji, Donia; Martin-Fernandez, L.; Amellal, Nadia; Furuse, Junji
err分享
err收藏
Five-year overall survival (OS) and OS by baseline liver function from the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC)Tremelimumab (T) 联合 Durvalumab (D) 治疗不可切除性肝细胞癌(uHCC)的III期HIMALAYA研究中,基于基线肝功能的5年总生存期(OS)和总生存期(OS)。
err2024-12-01
err1
PREAI
errKudo, M.; Rimassa, L.; Chan, S. L.; Sangro, B.; Lau, G.; Breder, V. V.; Varela, M.; Crysler, O. V.; Bouattour, M.; Dao, V. T.; Faccio, A.; Furuse, J.; Jeng, L-B.; Kang, Y-K.; Kelley, R. K.; Paskow, M. J.; Makowsky, M.; Ran, D.; Negro, A.; Abou-Alfa, G. K.
err分享
err收藏
KEYNOTE-966: 3-year follow-up for pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) vs placebo (pbo) plus gem/cis for patients (pts) with advanced biliary tract cancer (BTC)KEYNOTE-966: Pembrolizumab(pembro)联合吉西他滨和顺铂(gem/cis)对比安慰剂(pbo)联合吉西他滨和顺铂,用于晚期胆道癌(BTC)患者的3年随访研究。
err2024-12-01
err1
PREAI
errUeno, M.; Finn, R. S.; Yoo, C.; Ren, Z.; Furuse, J.; Kelley, R. K.; Chan, S. L.; Edeline, J.; Klumpen, H. J.; Yau, T.; Verslype, C.; Ozaka, M.; Bouattour, M.; Park, J. O.; Vogel, A.; Valle, J. W.; Starkopf, L.; Malhotra, U.; Siegel, A. B.; Qin, S.
err分享
err收藏
Plain language summary: an analysis of the safety of futibatinib treatment in people with different types of cancer通俗易懂的总结: 不同类型癌症患者使用futibatinib治疗的安全性分析
err2024-10-28
err0
errOAAI
errMeric-Bernstam, Funda; Hollebecque, Antoine; Furuse, Junji; Oh, Do-Youn; Bridgewater, John A.; Anderson, Bailey; Hangai, Nanae; Wacheck, Volker; Goyal, Lipika
err分享
err收藏
Patient and physician preferences for systemic therapy combined with TACE for hepatocellular carcinoma
err2024-10-01
err0
PREAI
errFuruse, J.; Shirakawa, S.; Fukui, A.; Hirai, T.; Kobayashi, T.; Hamada, Y.; Kitagawa, H.
err分享
err收藏
Short-term outcomes of nivolumab plus chemotherapy for advanced gastric neuroendocrine cell carcinoma
err2024-10-01
err0
PREAI
errOnishi, M.; Furuta, M.; Hama, T.; Furusawa, K.; Hayashi, K.; Inokuchi, Y.; Furuse, J.; Machida, N.; Maeda, S.
err分享
err收藏
Phase I/II study of nivolumab plus lenvatinib for advanced biliary tract cancer (JCOG1808/NCCH1817, SNIPE)nivolumab联合lenvatinib治疗晚期胆道癌的I/II期研究 (JCOG1808/NCCH1817,SNIPE)
err2024-10-01
err0
errOAAI
errUeno, M.; Morizane, C.; Ikeda, M.; Ozaka, M.; Nagashima, F.; Kataoka, T.; Mizusawa, J.; Ohba, A.; Kobayashi, S.; Imaoka, H.; Kasuga, A.; Okano, N.; Nagasaka, Y.; Sasaki, M.; Furuse, J.; Okusaka, T.
err分享
err收藏
err分享
err收藏
Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after FOLFIRINOX or gemcitabine plus nab-paclitaxel chemotherapy: A multicenter retrospective cohort study (PC-CURE-1)
err2024-08-16
err1
errOAAI
errOkano, Naohiro; Kawai, Manabu; Ueno, Makoto; Yu, Xianjun; Inoue, Yosuke; Takahashi, Shinichiro; Wang, Wenquan; Takahashi, Hidenori; Okamura, Yukiyasu; Morinaga, Soichiro; Matsumoto, Ippei; Shimizu, Yasuhiro; Yoshida, Kazuhiro; Yamamoto, Tomohisa; Ohtsuka, Masayuki; Inokawa, Yoshikuni; Nara, Satoshi; Tamura, Jun; Shinoda, Satoru; Yamamoto, Kouji; Yamaue, Hiroki; Furuse, Junji
err分享
err收藏
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancerFOENIX-CCA2研究的简明语言摘要: futibatinib用于晚期胆管癌患者
err2024-06-17
err0
errOAAI
errGoyal, Lipika; Meric-Bernstam, Funda; Hollebecque, Antoine; Valle, Juan W.; Morizane, Chigusa; Karasic, Thomas B.; Abrams, Thomas A.; Furuse, Junji; Kelley, Robin Katie; Cassier, Philippe A.; Klumpen, Heinz-Josef; Chang, Heung-Moon; Chen, Li-Tzong; Tabernero, Josep; Oh, Do-Youn; Mahipal, Amit; Moehler, Markus; Komatsu, Yoshito; Ahn, Daniel H.; Epstein, Robert S.; Halim, Abdel-Baset; Wacheck, Volker; He, Yaohua; Liu, Mei; Benhadji, Karim A.; Bridgewater, John A.
err分享
err收藏
Bintrafusp alfa and chemotherapy as first-line treatment in biliary tract cancer: A randomized phase 2/3 trial
err2024-06-14
err0
errOAAI
errOh, Do-Youn; Ikeda, Masafumi; Lee, Choong-kun; Rojas, Carlos; Hsu, Chih-Hung; Kim, Jin Won; Shen, Lin; Furuse, Junji; Park, Joon Oh; Borad, Mitesh; de Braud, Filippo; Bridgewater, John; Lee, Sunyoung S.; Moehler, Markus; Audhuy, Francois; Osada, Motonobu; Sato, Masashi; Yoo, Changhoon
err分享
err收藏
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinomatremelimumab联合durvalumab治疗不可切除肝细胞癌的III期喜马拉雅研究的四年总生存期更新
err2024-05-01
err39
errOAAI
errSangro, B.; Chan, S. L.; Kelley, R. K.; Lau, G.; Kudo, M.; Sukeepaisarnjaroen, W.; Yarchoan, M.; De Toni, E. N.; Furuse, J.; Kang, Y. K.; Galle, P. R.; Rimassa, L.; Heurgue, A.; Tam, V. C.; Van Dao, T.; Thungappa, S. C.; Breder, V.; Ostapenko, Y.; Reig, M.; Makowsky, M.; Paskow, M. J.; Gupta, C.; Kurland, J. F.; Negro, A.; Abou-Alfa, G. K.
err分享
err收藏